Expression studies obtained by qRT-PCR on day 21 tumor nodules, confirmed a HXR9-based down-regulation of miR-221 and -222 followed by c-FOS restored expression also in vivo (Fig. 6g), further supporting the option of c-FOS as a direct target of miR-221&222. This evidence concerns the gene FOS and neoplasm.